Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Scientists at Myrexis synthesize new IKK-epsilon inhibitors

Nov. 15, 2012

Tiltan Pharma enrolls first U.S. patient in phase II TL-118 study

Nov. 14, 2012

Joint effort between Eisai and Epizyme results in new EZH2 inhibitors

Nov. 14, 2012

Sunshine Biopharma begins IND-enabling studies for Adva-27a

Nov. 14, 2012

Researchers divulge new SERMs for the treatment of breast cancer

Nov. 14, 2012

AstraZeneca presents novel PI3K inhibitors

Nov. 14, 2012

Foundation Medicine develops genomic profiling collaborations

Nov. 14, 2012

Vaccibody receives grant to develop therapeutic cervical cancer vaccine

Nov. 14, 2012

Aeterna Zentaris' phase I/II study of AEZS-108 advances

Nov. 14, 2012

China's State Food and Drug Administration approves first-in-human trial of APX-003

Nov. 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....